December 15, 2009 04:00 ET

IDBS Named in Leading Analyst Research on Interactive Visualization for Business Intelligence

GUILDFORD, UK and BURLINGTON, MA--(Marketwire - December 15, 2009) - IDBS, the leading worldwide provider of research data management and analytics solutions to R&D organizations, today announced that it has been included in a recent research report from Gartner, "Who's Who in Interactive Visualization for BI," by James Richardson, published November 13, 2009.

According to Gartner, "interactive visualization helps business intelligence (BI) become more usable and insightful." Moreover, "whether it is incorporated into a dashboard or exists as a stand-alone analysis tool, better interactive visualization is a valuable addition to the BI platform, as it applies users' innate visual ability to aid understanding of patterns, for example, in a much more effective fashion than tabulated figures."

IDBS' VisualSense was named in the report for its advanced visual analytics capabilities. VisualSense is a component of the IDBS InforSense Suite for data integration, analysis and visualization, which helps organizations to make the most effective use of critical scientific data. With VisualSense, scientists and researchers can use highly interactive web-based reports and dashboards that enable them to quickly and easily spot trends in data, see deviations from those trends, identify outliers and detect data quality issues that might otherwise go unnoticed.

VisualSense provides a comprehensive set of charts, including heat maps, scatter plots and trellis views, as well as interactive capabilities that allow groups of data points to be selected and further analyzed, or that enable outliers to be deleted and curves recalculated. This level of interaction helps researchers to understand research and development data more quickly.

"We are delighted to be included in this Gartner report, which we believe reflects our valuable and unique scientific data analysis and visualization capabilities," said Neil Kipling, founder and CEO of IDBS. "The InforSense Suite plays a critical role in translational and biomarker research at leading drug discovery and medical research organizations around the world. With version 5.1 of the InforSense Suite launching in early 2010, users will have even more control over their visualizations. We consider this report further validation of the effectiveness and usability of our innovative technologies. Not only does this reflect that we have the premier solution in the scientific space, but also that we can provide the features and benefits demonstrated by today's mainstream BI vendors."

About IDBS

IDBS is a unique, global supplier of innovative data management and analytics solutions, which increase efficiency, reduce costs and improve business and scientific productivity of R&D organizations worldwide. Organizations such as Pfizer, GSK, Celera, MedImmune, Dana-Farber and Roche employ IDBS solutions as an integral part of their strategy to address the increasing pressures placed upon them by the need for the secure, compliant capture, integration and analysis of complex research data. IDBS is clearly differentiated from other software providers by its unique combination of deep domain knowledge and its ability to rapidly provide integrated business process and robust data analytics solutions along the entire R&D value chain. IDBS solutions secure organizations' valuable R&D data assets and enable rapid decision-making through effective integration and analysis. They also support the protection of Intellectual Property (IP) and the requirements for data quality demanded under Good Laboratory Practice (GLP) and Good Manufacturing Practice (GMP) standards.

IDBS is a private company, founded in 1989 and headquartered in Guildford, UK. IDBS has worldwide consulting and support presence, with U.S. offices in California, New Jersey and Massachusetts, the EU, Australia and China. Find out more at

Contact Information

  • Media enquiries:
    Danielle Guinebertiere
    Communications Director
    Tel: +1 908 429 2933
    Email: Email Contact